(Q44277060)

English

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models

scientific article published on 6 January 2010

Statements

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models (English)
Jeffrey L Brown
Z Alexander Cao
Maria Pinzon-Ortiz
Jane Kendrew
Corinne Reimer
Shenghua Wen
Joe Q Zhou
Mohammad Tabrizi
Steve Emery
Brenda McDermott
Lourdes Pablo
Patricia McCoon
Vahe Bedian
David C Blakey
6 January 2010
145-156

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit